In re Zalicus, Inc. Stockholders Litigation ( 2015 )


Menu:
  •                                     COURT OF CHANCERY
    OF THE
    STATE OF DELAWARE
    ANDRE G. BOUCHARD                                                   New Castle County Courthouse
    CHANCELLOR                                                       500 N. King Street, Suite 11400
    Wilmington, Delaware 19801-3734
    Date Submitted: January 13, 2015
    Date Decided: January 16, 2015
    Brian D. Long, Esquire
    Rigrodsky & Long, P.A.
    2 Righter Parkway, Suite 120
    Wilmington, DE 19803
    RE:    In re Zalicus, Inc. Stockholders Litigation
    Consolidated C.A. No. 9602-CB
    Dear Counsel:
    I have reviewed your letter dated January 13, 2015, notifying the Court that
    Defendant Zalicus, Inc. (“Zalicus”) has agreed to pay Plaintiffs’ counsel a “mootness fee”
    in the amount of $400,000, and requesting that I enter an order closing this case. For the
    following reasons, I decline to enter the proposed order because the parties have not
    given adequate notice of the stipulated mootness fee to the putative class.
    Plaintiffs filed this putative class action alleging that the directors of Zalicus had
    breached their fiduciary duties in connection with their approval of a stock-for-stock
    merger with Epirus Biopharmaceuticals, Inc. On June 13, 2014, I denied Plaintiffs’
    motion for expedited proceedings because I concluded that the claims presented in
    support of that motion were not colorable. On July 15, 2014, the stockholders of Zalicus
    approved the proposed merger, which closed that day.
    In re Zalicus, Inc. Stockholders Litigation
    Consol. C.A. No. 9602-CB
    January 16, 2015
    Page 2 of 5
    On November 12, 2014, I granted a stipulated order (the “Dismissal Order”) in
    which the parties agreed that this action “is dismissed without prejudice as to all
    plaintiffs” and that the Court would retain jurisdiction “solely for determining plaintiffs’
    forthcoming Fee and Expense Application.”           When they filed the Dismissal Order,
    Plaintiffs contended that supplemental disclosures by Zalicus had mooted certain of their
    breach of fiduciary duty claims.
    On January 13, 2015, the parties agreed in a Stipulation Regarding Attorneys’
    Fees and Expenses (the “Fee Stipulation”) that Zalicus (or its “successor(s) or applicable
    insurer(s)”) would pay “a combined, global fee in the amount” of $400,000 to Plaintiffs’
    counsel in this action and counsel for other Zalicus stockholders who commenced similar
    litigation in Massachusetts “in full satisfaction of plaintiffs’ counsel’s claim for
    attorney’s fees and expenses.” The parties now request that the Court enter another
    stipulated order (the proposed “Closure Order”) providing that the Court no longer retain
    jurisdiction over this action and that this action be closed for all purposes.
    Plaintiffs contend that “notice to the class should not be required” before the Court
    may enter the Closure Order because the “Court need not approve or take any action with
    respect to the Fee Stipulation.” Pls.’ Letter at 2, 3. Rather, according to Plaintiffs,
    Zalicus has exercised its business judgment to expend corporate funds to resolve
    Plaintiffs’ anticipated application for an award of attorney’s fees and expenses
    concerning claims that have been mooted.
    In re Zalicus, Inc. Stockholders Litigation
    Consol. C.A. No. 9602-CB
    January 16, 2015
    Page 3 of 5
    Although it is true that the Court is not being asked to take any action with respect
    to the Fee Stipulation, I conclude that, under this Court’s precedents, notice of the Fee
    Stipulation nevertheless should be given to the putative class of Zalicus stockholders
    before I may enter an order closing this case.
    Chancellor Allen’s opinion in Advanced Mammography sets forth the framework
    for this Court to address a joint application to dismiss claims as moot and for a mootness
    fee award. See In re Advanced Mammography Sys., Inc. S’holders Litig., 
    1996 WL 633409
    (Del. Ch. Oct. 30, 1996). In Advanced Mammography, no notice of the joint
    application had been given to the putative class. Chancellor Allen concluded that notice
    of the joint application must be given to the putative class because of “the risk of buy off”
    presented by the proposed fee payment. See 
    id. at *1;
    see also In re Cellular Commc’ns
    Int’l, Inc. S’holders Litig., 
    752 A.2d 1185
    , 1188 (Del. Ch. 2000) (citing Advanced
    Mammography, 
    1996 WL 633409
    , at *1) (“Ordinarily, notice of the decision to dismiss
    [claims on mootness grounds] and the terms of the [mootness] fee arrangement must be
    disclosed to the class and a hearing held.”).
    Vice Chancellor Laster recently addressed a variation of this procedure in Astex,
    where – similar to this case – the parties (i) agreed to dismiss the named plaintiffs’ claims
    as moot with prejudice (but without prejudice to other members of the class); 1 (ii)
    1
    As noted above, unlike Astex, paragraph 1 of the Dismissal Order in this case provides
    that the action “is dismissed without prejudice to all plaintiffs.”
    In re Zalicus, Inc. Stockholders Litigation
    Consol. C.A. No. 9602-CB
    January 16, 2015
    Page 4 of 5
    stipulated that the Court retain jurisdiction to hear the plaintiffs’ attorneys’ fees
    application; (iii) subsequently agreed to a stipulated mootness fee; and (iv) moved to
    have the Court close the case. See In re Astex Pharm., Inc. S’holders Litig., 
    2014 WL 4180342
    (Del. Ch. Aug. 25, 2014). In Astex, no notice of the stipulated mootness fee had
    been given to the class, which had been certified under Court of Chancery Rule 23.
    Applying the principles of Advanced Mammography, Vice Chancellor Laster reasoned
    that staggering the dismissal of claims and the agreement on fees “did not eliminate the
    risk” of a buy off. See 
    id. at *2.
    Thus, he denied the request to enter the proposed
    closure order without first affording notice to the class of the stipulated mootness fee.
    I see no compelling reason why I should depart from Astex here. I am not
    persuaded by Plaintiffs’ attempt to distinguish Astex on the grounds that no class has been
    certified in this case. Plaintiffs have not explained why class certification should be
    dispositive of whether notice is required under Advanced Mammography, and, in my
    view, the existence of a certification order was irrelevant to the Court’s ruling in Astex.
    In particular, I am hard-pressed to understand the relevance of a certification order in this
    context where no members of the class have released any claims and the class members’
    claims were dismissed without prejudice. To my mind, the rationale underlying Astex,
    which is equally applicable here, is that notice is appropriate because it provides the
    information necessary for an interested person to object to the use of corporate funds,
    such as by “challeng[ing] the fee payment as waste in a separate litigation,” if the
    In re Zalicus, Inc. Stockholders Litigation
    Consol. C.A. No. 9602-CB
    January 16, 2015
    Page 5 of 5
    circumstances warrant. See Hack v. Learning Co., 
    1996 WL 633309
    , at *2 (Del. Ch. Oct.
    29, 1996).
    For the foregoing reasons, Plaintiffs’ motion to enter the proposed Closure Order
    is DENIED. Should the parties elect to submit a revised order providing notice to the
    members of the putative class, the parties are directed to explain (i) what form the notice
    should take in these circumstances to be adequate while being sensitive to the cost
    considerations of providing notice, and (ii) what, if any, further proceedings are
    necessary before this action may be closed.
    IT IS SO ORDERED.
    Sincerely,
    /s/ Andre G. Bouchard
    Chancellor
    AGB/gp
    cc:  Rudolf Koch, Esquire
    David J. Teklits, Esquire
    Ryan M. Ernst, Esquire
    

Document Info

Docket Number: CA 9602-CB

Judges: Bouchard C.

Filed Date: 1/16/2015

Precedential Status: Precedential

Modified Date: 1/16/2015